Dieses Seminar hat leider schon statt gefunden. Wenn Sie aber Interesse an diesem Seminar haben, informieren wir Sie gerne über den neuen Termin oder über weitere Angebote zu dem Thema. Nutzen Sie einfach das folgende Kontaktformular, um uns Ihre Anfrage zu senden.
Tel.: 06221 / 84 44 0 E-Mail: firstname.lastname@example.org
Frank Behnisch, CSL Behring GmbH, Germany
Dr David Selby, Selby Hope International, UK
Dr Robert Stephenson, Rob Stephenson Consultancy, UK
This is why you should attend this course:
You will systematically be introduced to the principles and methods of the validation of computerised systems (according to GAMP®)
You will learn the skills to plan, implement and document effectively validation activities for computerised systems and to assess them with respect to their GxP compliance
You have the opportunity to practically apply the theoretical foundations in 7 workshops
Computerised systems are a central factor determining work sequences in the pharmaceutical industry. Their use increases product safety and saves time and costs of manual intervention. This creates the requirement and necessity, however, to validate all computerised systems which can influence the quality of pharmaceutical products.
The basis of the education course will be the current requirements for the validation of computerised systems like GAMP® and their GxP-oriented application in practice.
Experts from the pharmaceutical industry and from the GAMP® Committee will show you efficient ways to validate your computerised systems.
This course is directed towards specialists and executives in the pharmaceutical industry entrusted with the planning, implementation and evaluation of the validation of computerised systems.
Introduction –What the Participants Expect
An open session capturing the expectations of the delegates
Laws, Regulations and Guidelines for Computer
The historical perspective
Current regulations and regulatory guidelines from US
New regulatory guidance (GAMP® 5, GAMP® Good Practice Guides, ASTM)
New industry guidance
Electronic Records and Signatures
What Part 11 means – Now!
Identify e-records in predicate rules
Identify risks to records
Identify appropriate controls for records
The EU Annex 11 “Computerised Systems”
What is new?
What are the important points?
How can you implement it?
The GAMP® 5 Approach to Computer Validation
Validation needs structure
The GAMP® approach
What is new in GAMP® 5
General validation activities
The GAMP® Categorisation System
Life Cycle cost reduction
Risk Management – A Key Point Review
How to use the FMEA tool to reach better risk-based
How to make use of risk information
Programme 2nd Day
Why is a validation plan important?
Definitions and regulatory expectations
Building risk management into planning phase
Structure and contents of validation plans
Discussion of best approach
The impact of scaleability
Specifications, Design Review and Traceability
What sorts of specifications are needed?
How are they constructed?
Can they be combined?
How to carry out a design review?
How to construct a traceability matrix?
Protocols, Test Scripts and Deviation Management
Principles of Risk-Based Qualification
Leveraging the Supplier
Commissioning vs Qualification
Test Script Design
Sources of changes
Programme 3rd Day
GAMP® and risk analysis
Qualification / Validation
Validation Reporting & Presentation to Inspectors
The link between the plan and the report
Validation summary reports
Style and emphasis
Managing the inspection
Introduction to IT-Infrastructure Qualification
The qualification lifecycle
How to deal with user requirements
Qualification summery report
Recent general trends
Highlights from Warning Letters and 483s
Lessons we must learn
Self Evaluation of Compliance with Annex 11
Review of User Requirements Specifications
A short review of the URS and how to write specifications, as a prelude to a workshop in which delegates will evaluate a real requirements specification.
What is a URS?
Why is it important?
Contents of a URS
Characteristics of good specifications
Based on considerations of the type of application, knowledge of the supplier and how it will be used, delegates will work out the best approach to delivering the benefits of a GxP system
What are the risks associated with delivering the system?
What options do you have to manage the most critical risks?
How can they best be managed?
What are the key issues to monitor to ensure delivery of the project benefits?
Risk Management in Protocol Planning
Based on a real case study, delegates will use the same risk assessment techniques as in Workshop 2 to determine where to focus the qualification of a packaging line.
Risk management applied to a control system
Using FMEA to assess risks to be managed and
controlled in validation
Identifying options to mitigate (reduce) the higher risks Using the output in creating the testing protocol
The participants will work on a number of case studies and define the change control activities needed.
Change Control forms
In this workshop examples of deviations will be examined and methods of resolution discussed. The examples are based on real-life protocols.
Test failures found during IQ/OQ
Manage the deviations